R
Revelation Biosciences, Inc. Common StockREVB
Revelation Biosciences, Inc. is a clinical stage life sciences company focused on rebalancing inflammation using its proprietary formulation Gemini. Revelation has multiple ongoing programs to evaluate Gemini, including the treatment of chronic kidney disease, prevention for post-surgical infection and as a treatment for acute kidney.
US StocksHealthcareSmall CapBiotechnology
REVB Price Trend
Revelation Biosciences, Inc. Common Stock · Full TradingView Chart
NASDAQ:REVB